Please use this identifier to cite or link to this item: https://doi.org/10.1038/cddis.2016.12
Title: Loss of fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis
Authors: Huo, J
Ma, Y
Liu, J.-J
Ho, Y.S
Liu, S
Soh, L.Y
Chen, S
Xu, S 
Han, W 
Hong, A
Lim, S.C
Lam, K.-P 
Keywords: apoptosis regulatory protein
FAIM protein, human
Faim protein, mouse
insulin
animal
C57BL mouse
deficiency
energy metabolism
female
human
knockout mouse
lipogenesis
male
metabolism
middle aged
mouse
nonalcoholic fatty liver
obesity
Animals
Apoptosis Regulatory Proteins
Energy Metabolism
Female
Humans
Insulin
Lipogenesis
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Middle Aged
Non-alcoholic Fatty Liver Disease
Obesity
Issue Date: 2016
Publisher: Nature Publishing Group
Citation: Huo, J, Ma, Y, Liu, J.-J, Ho, Y.S, Liu, S, Soh, L.Y, Chen, S, Xu, S, Han, W, Hong, A, Lim, S.C, Lam, K.-P (2016). Loss of fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis. Cell Death and Disease 7 (2) : e2091. ScholarBank@NUS Repository. https://doi.org/10.1038/cddis.2016.12
Rights: Attribution 4.0 International
Abstract: Altered hepatic lipogenesis is associated with metabolic diseases such as obesity and hepatosteatosis. Insulin resistance and compensatory hyperinsulinaemia are key drivers of these metabolic imbalances. Fas apoptosis inhibitory molecule (FAIM), a ubiquitously expressed antiapoptotic protein, functions as a mediator of Akt signalling. Since Akt acts at a nodal point in insulin signalling, we hypothesize that FAIM may be involved in energy metabolism. In the current study, C57BL/6 wild-type (WT) and FAIM-knockout (FAIM-KO) male mice were fed with normal chow diet and body weight changes were monitored. Energy expenditure, substrate utilization and physical activities were analysed using a metabolic cage. Liver, pancreas and adipose tissue were subjected to histological examination. Serum glucose and insulin levels and lipid profiles were determined by biochemical assays. Changes in components of the insulin signalling pathway in FAIM-KO mice were examined by immunoblots. We found that FAIM-KO mice developed spontaneous non-hyperphagic obesity accompanied by hepatosteatosis, adipocyte hypertrophy, dyslipidaemia, hyperglycaemia and hyperinsulinaemia. In FAIM-KO liver, lipogenesis was elevated as indicated by increased fatty acid synthesis and SREBP-1 and SREBP-2 activation. Notably, protein expression of insulin receptor beta was markedly reduced in insulin target organs of FAIM-KO mice. Akt phosphorylation was also lower in FAIM-KO liver and adipose tissue as compared with WT controls. In addition, phosphorylation of insulin receptor substrate-1 and Akt2 in response to insulin treatment in isolated FAIM-KO hepatocytes was also markedly attenuated. Altogether, our data indicate that FAIM is a novel regulator of insulin signalling and plays an essential role in energy homoeostasis. These findings may shed light on the pathogenesis of obesity and hepatosteatosis. © 2016 Macmillan Publishers Limited All rights reserved.
Source Title: Cell Death and Disease
URI: https://scholarbank.nus.edu.sg/handle/10635/180385
ISSN: 2041-4889
DOI: 10.1038/cddis.2016.12
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_cddis_2016_12.pdf2.06 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

10
checked on Oct 20, 2021

Page view(s)

88
checked on Oct 21, 2021

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons